The promise of precision medicine is that all sorts of information about you—your genetics, ethnicity, diet, even neighborhood—could be used to create highly personalized treatments for whatever ails you, replacing the one-size-fits-all medicine of the past.
Doctors hope this will make everyone healthier. But a new report by the Data & Society Research Institute in New York says certain groups in the US are in jeopardy of being worse off when medicine is tailor-made. The one group notably not at risk: white men who can afford health insurance and a decent lifestyle.
So who stands to lose?
The uninsured. Precision medicine relies on researchers’ having lots of data. In the US, that data comes from electronic health records that doctors update when they see patients. Relatively little information gets collected about the uninsured and people who don’t see a doctor regularly. Those folks are most likely to be young adults and the poor.
The health-illiterate. A handful of big, ongoing precision-medicine studies are looking at people who wear electronic trackers to monitor their vital signs. Those people tend to be early adopters of technology. They’re likely to be physically active, interested in improving their health, well educated, and living near major cities. Researchers will need to find ways to get people who are less “health literate” to join such studies; otherwise precision medicine may end up mostly benefiting urban elites.
Women and minorities. These groups of people have often been excluded from medical research, so precision medicine that relies on historical data could be inherently biased. For example, guidelines for lung cancer screening in the US are based on a study of 53,000 people, only 4 percent of whom were African-American, according to Karriem Watson, a University of Chicago researcher quoted in the report. Similarly, what doctors know about cardiovascular disease comes mainly from research on men.
Immigrants. Some worry that the findings of precision-medicine research could be used to further discriminate against people who are already marginalized. Suppose, for instance, that researchers uncover a new health risk in a certain racial or ethnic group. Bioethicist Lisa Parker says we would then “have a health-related reason to limit those immigrants coming to this country and presenting a health burden for our health-care system.”
People in poor health. Because precision medicine would produce personalized health recommendations, it would be likely to put more responsibility on individuals to take charge of their own health. Those who do it best would be the “uncommonly tech savvy, highly health literate, self-directed, information seeking, English fluent, health focused, and well insured,” according to bioethicist Mark Rothstein, quoted in the report. Meanwhile, for people without resources and those already in poor health, the recommendations could feel confusing, overwhelming, and even intrusive, causing them to distrust the information they’re getting.
This scientist now believes covid started in Wuhan’s wet market. Here’s why.
How a veteran virologist found fresh evidence to back up the theory that covid jumped from animals to humans in a notorious Chinese market—rather than emerged from a lab leak.
The US crackdown on Chinese economic espionage is a mess. We have the data to show it.
The US government’s China Initiative sought to protect national security. In the most comprehensive analysis of cases to date, MIT Technology Review reveals how far it has strayed from its goals.
The China Initiative’s first academic guilty verdict raises more questions than it answers
Observers hoped that the trial of the prominent Harvard professor Charles Lieber would provide some clues into the future of the Department of Justice’s campaign against Chinese economic espionage.
This is one reason why being online felt so bad in 2021
New data shows just how polarized political conversation is in the US and hints at what might come during the 2022 midterms.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.